Talphera, Inc. (TLPH) Stock Analysis & Investment Frameworks
Talphera, Inc. (TLPH) stock analysis on Invetso. Review Talphera, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Talphera, Inc. Company Overview
- Exchange: NASDAQ Global Market
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Country: US
Talphera, Inc. Key Financial Metrics
- Market Cap: $55.28M
- Revenue: $28000.00
- ROE: -87.28%
- ROIC: -65.20%
- Dividend Yield: N/A
About Talphera, Inc.
Talphera, Inc. is a specialty pharmaceutical company focused on developing and commercializing therapeutic products intended for use in carefully monitored medical environments. Their lead experimental candidate is Niyad, a lyophilized (freeze-dried) formulation of nafamostat. This anticoagulant is currently being assessed under an investigational device exemption for its application in extracorporeal circuits. The company's development pipeline also features LTX-608, a potential anti-inflammatory and antiviral agent being explored for the treatment of numerous conditions, including COVID-19, disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis. Furthermore, Talphera is advancing Fedsyra, a pre-filled syringe containing ephedrine, and PFS-02, a pre-filled syringe containing phenylephrine. Established in 2005, the company was previously known as AcelRx Pharmaceuticals, Inc. It adopted the name Talphera, Inc. in January 2024 and maintains its corporate headquarters in San Mateo, California.
Talphera, Inc. Investment Frameworks
Invetso analyzes Talphera, Inc. (TLPH) across the following frameworks:
- Talphera, Inc. 10Y Growth Potential
- Talphera, Inc. Scenario Analysis
- Talphera, Inc. Risks & Opportunities
- Talphera, Inc. Economic Moat
- Talphera, Inc. Business Model
- Talphera, Inc. Management
- Talphera, Inc. SWOT Analysis
- Talphera, Inc. Porter's 5 Forces
- Talphera, Inc. PESTLE Analysis
- Talphera, Inc. ESG Analysis